According to Gram Research analysis, the VITALITY study is a large randomized controlled trial of 2,739 Australian infants testing whether 400 IU of daily vitamin D supplementation in the first year of life prevents food allergies and strengthens immune health. Researchers completed objective allergy testing on 2,151 babies at 12 months and are now following the cohort through age six to determine long-term effects on asthma, allergies, and other conditions. Final results are pending, but the study’s rigorous design and high retention rate (over 83%) suggest findings will provide reliable guidance for infant vitamin D supplementation.
Researchers in Australia are studying whether giving babies vitamin D supplements in their first year of life can help prevent food allergies and boost immune health. The VITALITY study followed nearly 2,740 healthy breastfed infants from 2014 to 2022, giving some babies 400 IU of vitamin D daily and others a placebo. The study collected detailed information about allergies, feeding, and environmental factors, plus biological samples like blood and stool. Now researchers are following these children into their school years to see if early vitamin D supplementation protects against asthma, allergies, and other health conditions. This large, well-designed study could help doctors understand whether a simple vitamin supplement in infancy might prevent common childhood diseases.
Key Statistics
A 2026 randomized controlled trial of 2,739 breastfed infants in Australia found that researchers successfully retained over 83% of families through the first year of follow-up despite the COVID-19 pandemic, with 79% attending objective allergy testing at 12 months.
The VITALITY study performed skin prick tests on 2,151 infants and conducted oral food challenges on 612 infants at 12 months of age, with 89.2% of participants having a family history of allergic disease, making this a high-risk cohort for allergy development.
A 2026 longitudinal cohort study of 2,739 infants found that 61.2% had both parents born in Australia, while 89.2% had at least one parent with a history of allergic disease, indicating strong genetic risk factors for allergy in the study population.
The Quick Take
- What they studied: Whether giving babies vitamin D supplements (400 IU daily) during their first year of life reduces food allergies and strengthens their immune system compared to babies who received a placebo (fake pill).
- Who participated: 2,739 healthy, full-term breastfed babies born in Melbourne, Australia between 2014 and 2022. Most families had a history of allergies, and about 61% had both parents born in Australia. The study kept track of over 83% of families even during the COVID-19 pandemic.
- Key finding: The VITALITY study successfully enrolled and tracked nearly 2,740 infants through their first year with detailed allergy testing (skin prick tests on 2,151 babies and food challenges on 612 babies) and biological samples. The study is now following these children into their school years to determine if early vitamin D supplementation prevents allergies, asthma, and other health problems.
- What it means for you: This research is still ongoing, so we don’t yet have final answers about whether vitamin D prevents allergies in babies. However, the study’s strong design and detailed tracking mean the results, when available, will provide reliable guidance for parents and doctors about infant vitamin D supplementation. Talk to your pediatrician about vitamin D for your baby while waiting for these findings.
The Research Details
VITALITY is a randomized controlled trial, which is considered the gold standard for medical research. Researchers randomly assigned nearly 2,740 healthy breastfed infants to receive either 400 IU of vitamin D daily or a placebo (inactive pill) that looked identical. Neither the families nor the researchers knew which babies received the real vitamin D, making it double-blind. This design prevents bias and ensures any differences between groups are due to the vitamin D, not other factors.
The study collected information at multiple timepoints: at baseline (6 to 12 weeks old), then at 6 months, 9 months, and 12 months of age. Families answered detailed questionnaires about their baby’s health, diet, allergies, and environmental exposures. At 12 months, 79% of families attended clinic visits where researchers performed skin prick tests (a simple allergy test) on 2,151 babies and conducted oral food challenges on 612 babies to confirm food allergies. Researchers also collected biological samples including blood, stool, skin swabs, and breastmilk for advanced testing.
The study’s retention rate exceeded 83% despite the COVID-19 pandemic, demonstrating strong participant commitment. Researchers are now conducting a six-year follow-up to track whether early vitamin D supplementation affects asthma, other allergies, lung function, infections, and oral health as children grow.
This research design is important because it directly tests whether vitamin D causes allergy prevention, rather than just observing whether babies who happen to get vitamin D have fewer allergies. The randomized approach eliminates confounding factors (other differences between families that might affect results). The multiple timepoints and biological samples allow researchers to understand not just whether vitamin D works, but how it works by examining immune system markers. The long-term follow-up will reveal whether benefits persist or emerge as children age.
This study has several strengths that make its findings reliable: it’s large (2,739 participants), uses a randomized design with a placebo control group, maintains double-blinding to prevent bias, achieves high retention (over 83%), includes objective allergy testing (skin prick tests and food challenges) rather than relying only on parent reports, and collects biological samples for detailed analysis. The study was conducted in a single center in Australia, which ensures consistent methods but may limit generalizability to other populations. The ongoing six-year follow-up will provide evidence about long-term effects.
What the Results Show
The VITALITY study successfully established a large, well-characterized cohort of infants and completed the first year of follow-up with detailed allergy assessments. At 12 months of age, researchers performed skin prick tests on 2,151 infants (79% of the original cohort) and conducted oral food challenges on 612 infants to objectively measure food allergies. This high participation rate and objective testing approach provides a solid foundation for determining whether vitamin D supplementation affects allergy development.
The study collected extensive biological samples including blood, stool, skin swabs, and breastmilk from participants. These samples enable researchers to examine immune system markers and other biological factors that might explain how vitamin D influences allergy risk. The detailed questionnaire data captured information about family history of allergies (89.2% had at least one parent with allergic disease), feeding practices, environmental exposures, and other factors that influence vitamin D levels and immune function.
The cohort characteristics show that most participants had significant allergy risk: 89.2% had a family history of allergic disease, which is important because children with allergic relatives are at higher risk for developing allergies themselves. This high-risk population makes the study particularly valuable for understanding whether vitamin D can prevent allergies in vulnerable children.
The study collected data on multiple health outcomes beyond food allergies, including eczema (skin inflammation), which was assessed at the 12-month clinic visit. Researchers also gathered information on infant feeding practices and breastmilk composition, which are important factors influencing immune development. The environmental exposure data collected through questionnaires will allow researchers to examine how factors like pet exposure, daycare attendance, and household composition interact with vitamin D supplementation.
Previous research has suggested that vitamin D plays a role in immune function and may influence allergy risk, but results have been inconsistent. The VITALITY study improves upon earlier research by using a randomized controlled design (stronger than observational studies), including objective allergy testing rather than relying on parent reports, and following children over multiple years. The large sample size and high retention rate provide more reliable evidence than smaller studies. The biological sample collection allows researchers to examine immune mechanisms that previous studies could not assess.
The study was conducted in a single center in Melbourne, Australia, so results may not apply equally to all populations worldwide, particularly those with different genetic backgrounds or environmental exposures. The majority of participants were breastfed and had relatively high rates of family history of allergies, which may not represent all infant populations. The study is still ongoing, so the primary results about whether vitamin D actually prevents allergies have not yet been published. The six-year follow-up is underway, meaning we must wait for future publications to learn the main findings.
The Bottom Line
Current recommendations from pediatric organizations suggest that all breastfed infants receive vitamin D supplementation (typically 400 IU daily) because breastmilk alone may not provide adequate vitamin D. The VITALITY study will help clarify whether this supplementation also prevents allergies and other immune-related conditions. Parents should continue following their pediatrician’s vitamin D recommendations while awaiting the full results of this research. High confidence: vitamin D supplementation is safe and recommended for breastfed infants. Moderate confidence: vitamin D may help prevent allergies (results pending).
Parents of breastfed infants should pay attention to these findings, as they may influence vitamin D supplementation decisions. Children with family histories of allergies, asthma, or eczema are particularly relevant to this research. Healthcare providers including pediatricians, allergists, and public health officials will use these results to guide recommendations about infant vitamin D supplementation. The findings may eventually influence national guidelines for infant nutrition and allergy prevention. Formula-fed infants typically receive adequate vitamin D through fortified formula, so this research is most directly applicable to breastfed babies.
The VITALITY study is currently in its six-year follow-up phase, meaning primary results about food allergies at 12 months may be published within the next 1 to 2 years. Long-term outcomes regarding asthma, other allergies, and immune health will take several more years to analyze and publish. Parents should expect to see preliminary findings within 2 to 3 years, with comprehensive results available within 5 to 7 years. Any benefits from vitamin D supplementation would likely become apparent within the first few years of life, though some effects may emerge later in childhood.
Frequently Asked Questions
Should I give my breastfed baby vitamin D supplements?
Yes, pediatric organizations recommend 400 IU of vitamin D daily for all breastfed infants because breastmilk alone typically doesn’t provide adequate vitamin D. The VITALITY study is testing whether this supplementation also prevents allergies, with results coming in the next few years.
Can vitamin D prevent food allergies in babies?
The VITALITY study of 2,739 infants is investigating this question, with results pending. Previous research suggests vitamin D may influence allergy risk, but the VITALITY trial will provide the strongest evidence through its randomized design and objective allergy testing on 2,151 babies.
What is a randomized controlled trial and why does it matter?
A randomized controlled trial randomly assigns participants to receive either a treatment (vitamin D) or placebo, with neither group knowing which they received. This design eliminates bias and proves whether a treatment causes an effect, making it the gold standard for medical research.
How long will it take to know if vitamin D prevents allergies?
The VITALITY study is currently following children through age six. Preliminary results about food allergies at 12 months may be published within 1 to 2 years, while long-term findings about asthma and other allergies will take several additional years to analyze.
Does this study apply to formula-fed babies?
No, VITALITY specifically studied breastfed infants because they’re at higher risk for vitamin D deficiency. Formula-fed babies typically receive adequate vitamin D through fortified formula, so this research is most relevant to breastfeeding families.
Want to Apply This Research?
- Track your baby’s vitamin D supplementation compliance by logging daily doses in your health app, noting the date, time, and amount (400 IU). Record any allergic reactions or symptoms (rashes, vomiting, diarrhea) that occur within 24 hours of supplementation to identify potential adverse effects.
- Set a daily reminder on your phone or app to give your baby their vitamin D supplement at the same time each day (for example, with breakfast). This builds a consistent habit and ensures your baby receives the full recommended dose. Use your app to track which formulation you’re using (liquid drops, powder, or other) so you can maintain consistency.
- Use your health app to record any signs of allergies or immune-related conditions as your child grows: food reactions, eczema flares, respiratory infections, or asthma symptoms. Note the timing relative to vitamin D supplementation and other factors like new foods introduced or seasonal changes. Share this data with your pediatrician at regular checkups to help identify patterns and inform future supplementation decisions.
This article describes an ongoing research study. The primary results about whether vitamin D prevents food allergies have not yet been published. Current recommendations for infant vitamin D supplementation (400 IU daily for breastfed babies) are based on vitamin D deficiency prevention, not allergy prevention. Always consult your pediatrician before starting or changing your baby’s supplements. This information is for educational purposes and should not replace professional medical advice. Do not use this article to diagnose or treat allergies or other health conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.